Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

September 18, 2020

Primary Completion Date

October 24, 2023

Study Completion Date

January 22, 2024

Conditions
Pediatric Cancer
Interventions
OTHER

My Special Aflac Duck (MSAD)

The hospital Child Life Specialist or research team member will introduce the child and parent to My Special Aflac Duck MSAD), with instructions on how to use the duck. MSAD is a robotic toy with an associated app. Children can use MSAD for play, exploring feelings, and describing medical procedures. Intervention hospitals are permitted to provide their standard of care from Child Life with the exception of providing stuffed animal-like objects. Data will be recorded by Child Life or research team member on what tools are used outside of the MSAD.

BEHAVIORAL

Standard of care control

Sites will follow their individual standard of care from Child Life. Data will be recorded by Child Life on what tools are used. After completion of the 3-month survey, patients at hospitals assigned to not initially receive MSAD will each receive a MSAD.

Trial Locations (8)

23219

Children's Hospital of Richmond, Richmond

35233

Children's of Alabama, Birmingham

48109

C.S. Mott Children's Hospital, Ann Arbor

60637

Comer Children's Hospital, Chicago

63110

St. Louis Children's Hospital, St Louis

64108

Children's Mercy Kansas City, Kansas City

70118

Children's Hospital New Orleans, New Orleans

06106

Connecticut Children's Medical Center, Hartford

All Listed Sponsors
collaborator

American Family Life Assurance Company (Aflac Inc.)

UNKNOWN

lead

Emory University

OTHER

NCT04409301 - Distress in the Pediatric Oncology Setting: Intervention Versus Natural Adaptation | Biotech Hunter | Biotech Hunter